These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 15256312)
1. Pathophysiology, prognostic significance and clinical utility of B-type natriuretic peptide in acute coronary syndromes. Wiviott SD; de Lemos JA; Morrow DA Clin Chim Acta; 2004 Aug; 346(2):119-28. PubMed ID: 15256312 [TBL] [Abstract][Full Text] [Related]
2. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. de Lemos JA; Morrow DA; Bentley JH; Omland T; Sabatine MS; McCabe CH; Hall C; Cannon CP; Braunwald E N Engl J Med; 2001 Oct; 345(14):1014-21. PubMed ID: 11586953 [TBL] [Abstract][Full Text] [Related]
3. Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial). Bonaca MP; Wiviott SD; Sabatine MS; Buros J; Murphy SA; Scirica BM; Rifai N; Antman EM; Morrow DA Am J Cardiol; 2007 Feb; 99(3):344-8. PubMed ID: 17261395 [TBL] [Abstract][Full Text] [Related]
5. Natriuretic peptides for risk stratification of patients with acute coronary syndromes. Galvani M; Ferrini D; Ottani F Eur J Heart Fail; 2004 Mar; 6(3):327-33. PubMed ID: 14987584 [TBL] [Abstract][Full Text] [Related]
6. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Heeschen C; Hamm CW; Mitrovic V; Lantelme NH; White HD; Circulation; 2004 Nov; 110(20):3206-12. PubMed ID: 15533869 [TBL] [Abstract][Full Text] [Related]
7. The prognostic value of N-terminal proB-type natriuretic peptide. Costello-Boerrigter LC; Burnett JC Nat Clin Pract Cardiovasc Med; 2005 Apr; 2(4):194-201. PubMed ID: 16265483 [TBL] [Abstract][Full Text] [Related]
8. Short-term serial sampling of natriuretic peptides in patients presenting with chest pain. Kwan G; Isakson SR; Beede J; Clopton P; Maisel AS; Fitzgerald RL J Am Coll Cardiol; 2007 Mar; 49(11):1186-92. PubMed ID: 17367663 [TBL] [Abstract][Full Text] [Related]
9. B-type natriuretic peptide as an integrated risk marker in non-ST elevation acute coronary syndromes. Yamamoto T; Sato N; Yasutake M; Takagi H; Morita N; Akutsu K; Fujii M; Fujita N; Tanaka K; Takano T Int J Cardiol; 2006 Aug; 111(2):224-30. PubMed ID: 16185779 [TBL] [Abstract][Full Text] [Related]
10. The clinical role of natriuretic peptides--importance of BNP and NT-proBNP. Implications in heart failure and acute coronary syndrome. Machado M; Falcão LM; Ravara L Rev Port Cardiol; 2004; 23(7-8):1005-32. PubMed ID: 15478326 [TBL] [Abstract][Full Text] [Related]
11. N-terminal pro-brain natriuretic peptide for additional risk stratification in patients with non-ST-elevation acute coronary syndrome and an elevated troponin T: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy. Windhausen F; Hirsch A; Sanders GT; Cornel J; Fischer J; van Straalen JP; Tijssen JG; Verheugt FW; de Winter RJ; Am Heart J; 2007 Apr; 153(4):485-92. PubMed ID: 17383283 [TBL] [Abstract][Full Text] [Related]
12. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy. Mega JL; Morrow DA; De Lemos JA; Sabatine MS; Murphy SA; Rifai N; Gibson CM; Antman EM; Braunwald E J Am Coll Cardiol; 2004 Jul; 44(2):335-9. PubMed ID: 15261928 [TBL] [Abstract][Full Text] [Related]
13. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome. Narain VS; Gupta N; Sethi R; Puri A; Dwivedi SK; Saran RK; Puri VK Indian Heart J; 2008; 60(6):536-42. PubMed ID: 19276492 [TBL] [Abstract][Full Text] [Related]
14. [Atrial natriuretic peptides: a new diagnostic tool for the internist]. Boari B; Manfredini R; Fellin R Recenti Prog Med; 2005 Jun; 96(6):300-10. PubMed ID: 16078761 [TBL] [Abstract][Full Text] [Related]
15. Plasma levels of B-type natriuretic Peptide in patients with unstable angina pectoris or acute myocardial infarction: prognostic significance and therapeutic implications. Ahmed W; Zafar S; Alam AY; Ahktar N; Shah MA; Alpert MA Angiology; 2007; 58(3):269-74. PubMed ID: 17626979 [TBL] [Abstract][Full Text] [Related]
16. Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy. Lindahl B; Lindbäck J; Jernberg T; Johnston N; Stridsberg M; Venge P; Wallentin L J Am Coll Cardiol; 2005 Feb; 45(4):533-41. PubMed ID: 15708700 [TBL] [Abstract][Full Text] [Related]
17. Combining natriuretic peptides and necrosis markers in the assessment of acute coronary syndromes. de Lemos JA; Morrow DA Rev Cardiovasc Med; 2003; 4 Suppl 4():S37-46. PubMed ID: 14564227 [TBL] [Abstract][Full Text] [Related]
18. N-terminal probrain natriuretic peptide as a predictor of short-term outcomes in acute myocardial infarction. Puri A; Narain VS; Mehrotra S; Dwivedi SK; Saran RK; Puri VK Indian Heart J; 2005; 57(4):304-10. PubMed ID: 16350675 [TBL] [Abstract][Full Text] [Related]
19. Natriuretic peptides in unstable coronary artery disease. Jernberg T; James S; Lindahl B; Johnston N; Stridsberg M; Venge P; Wallentin L Eur Heart J; 2004 Sep; 25(17):1486-93. PubMed ID: 15342167 [TBL] [Abstract][Full Text] [Related]
20. Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes. O'Donoghue M; de Lemos JA; Morrow DA; Murphy SA; Buros JL; Cannon CP; Sabatine MS Circulation; 2006 Aug; 114(6):550-7. PubMed ID: 16880323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]